Statins and their effects on the peripheral nervous system

Česká verzia

Authors: Z. Kadaňka Jr.
Authors place of work: Neurologická klinika LF MU a FN Brno
Published in the journal: Cesk Slov Neurol N 2018; 81(1): 98-99
Category: Letter to Editor
doi: https://doi.org/10.14735/amcsnn201898

Summary

The author declares he has no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Zdroje

1. Lewington S, Whitlock G, Clarke R et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Prospective Studies Collaboration. Lancet 2007; 370(9602): 1829– 1839.

2. Heart Protection Study Collaborative Group. MRC/ BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360(9326): 7– 22.

3. Skilving I, Eriksson M, Rane et al. Statin-induced myopathy in a usual care setting – a prospective observational study of gender differences. Eur J Clin Pharmacol 2016; 72(10): 1171– 1176. doi: 10.1007/ s00228-016-2105-2.

4. Jeppesen U, Gaist D, Smith T et al. Statins and peripheral neuropathy. Eur J Clin Pharmacol 1999; 54(11): 835– 838.

5. Corrao G, Zambon A, Bertu L et al. Lipid lowering drugs prescription and the risk of peripheral neuropathy: an exploratory case-control study using automated databases. J Epidemiol Community Health 2004; 58(12): 1047– 1051. doi: 10.1136/ jech.2003.013409.

6. Otruba P, Kanovsky P, Hlustik P. Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up. Neuro Endocrinol Lett 2011; 32(5): 688– 690.

7. Zangiabadi N, Shafiee K, Alavi KH et al. Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial. Minerva Endocrinol 2012; 37(2): 195– 200.

8. Svendsen TK, Nørregaard Hansen P, García Rodríguez LA et al. Statins and polyneuropathy revisited: case-control study in Denmark, 1999– 2011. Br J Clin Pharmacol 2017; 83(9): 2087– 2095. doi: 10.1111/ bcp.13298.

9. Gaist D, Jeppesen U, Andersen L et al. Statins and risk of polyneuropathy: a case-control study. Neurology 2002; 58(9): 1333– 1337.

10. Novak P, Pimentel DA, Sundar B et al. Associationof statins with sensory and autonomic ganglionopathy. Front Aging Neurosci 2015; 7: 191. doi: 10.3389/ fnagi.2015.00191.